Clinical Trials Browser

Nonseminomatous germ cell tumor

NCT02044354 2026-04-01

CABA-DOC

Phase 3 Completed

195 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT01616875 2026-03-06

Bristol Bladder Trial

Phase 2 Completed

28 enrolled 21 charts

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT03556904 2026-01-15

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Phase 2 Completed

14 enrolled 16 charts

Genitourinary

Prostatic Neoplasms

NCT01420250 2025-05-15

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Phase 1 Completed

20 enrolled

Genitourinary

Prostatic Neoplasms

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Phase 2 Completed

14 enrolled 12 charts

Genitourinary

Carcinoma, Transitional Cell

NCT02218606 2024-12-10

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

81 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT02903160 2024-02-07

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Phase 2 Completed

40 enrolled 18 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02543255 2024-01-31

ACDC-RP

Phase 2 Completed

76 enrolled

Genitourinary

Prostatic Neoplasms

NCT03114254 2022-11-18

JAVA-P

Phase 2 Completed

17 enrolled

Genitourinary

Neoplasm Metastasis, Penile Neoplasms, Recurrence

NCT05471427 2022-07-22

ANCHISES

Completed

118 enrolled

Genitourinary

Prostatic Neoplasms

NCT03392428 2022-06-13

TheraP

Phase 2 Completed

201 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02961257 2022-05-12

CABASTY

Phase 3 Completed

196 enrolled

Genitourinary

Prostate Cancer Metastatic

NCT03295565 2022-04-15

OSTRICh

Phase 2/3 Completed

100 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT03101046 2022-02-10

TACTIK

Phase 2 Completed

40 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT01505868 2021-07-30

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Completed

170 enrolled 22 charts

Genitourinary

Lymphadenopathy, Prostatic Neoplasms

NCT01620242 2021-03-02

ORL03

Phase 2 Completed

31 enrolled

Head & Neck

Head and Neck Neoplasms, Recurrence

NCT02560337 2020-10-08

CaTo-ROC

Phase 2 Completed

26 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT02512458 2020-02-10

CABA-BONE

Phase 2 Completed

60 enrolled

Genitourinary

Bone Metastatic Prostate Cancer

NCT01668459 2018-12-04

CabB1

Phase 2/3 Completed

20 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT01956149 2018-04-18

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Phase 2 Completed

65 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01757171 2018-04-03

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Phase 2 Completed

85 enrolled 11 charts

Gastrointestinal

Stomach Neoplasms

NCT01866449 2017-10-26

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Phase 2 Completed

24 enrolled

CNS

Glioblastoma

NCT01693549 2017-08-01

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Phase 2 Completed

84 enrolled

Breast

Breast Neoplasms

NCT01594918 2017-07-21

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

25 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT01518283 2017-07-02

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Phase 2 Completed

74 enrolled

Genitourinary

Hormone Refractory Prostate Cancer

NCT01528163 2017-06-14

RACATREX

Phase 2 Completed

101 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT01438307 2017-05-24

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

28 enrolled 11 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01541007 2015-11-02

ConCab

Phase 2 Completed

100 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01852578 2015-09-28

Cabazitaxel in Relapsed and Metastatic NSCLC

Phase 2 Completed

46 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01600339 2015-05-12

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Phase 2 Completed

19 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT01379339 2015-02-11

Cabazitaxel - PF Induction Chemotherapy

Phase 1 Completed

40 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Clinical Trials

CABA-GCT

CABA-DOC

Bristol Bladder Trial

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

ACDC-RP

JAVA-P

ANCHISES

TheraP

CABASTY

OSTRICh

TACTIK

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

ORL03

CaTo-ROC

CABA-BONE

CabB1

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

RACATREX

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer

ConCab

Cabazitaxel in Relapsed and Metastatic NSCLC

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Cabazitaxel - PF Induction Chemotherapy